Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Psyomics

Request full access

Transforming the way mental health concerns are identified and stratified, paving the way for better understanding, treatment and outcomes

Milton, United KingdomFounded 2015Health Tech & Medtech

About Psyomics

Psyomics is a pioneering startup focused on revolutionizing mental health care through innovative digital solutions. The company operates primarily in the mental health sector, targeting both individual users and healthcare providers. Psyomics aims to improve mental health outcomes by emphasizing prevention, early diagnosis, and swift access to appropriate support.

The core offering of Psyomics is its digital diagnostic platform, Censeo. This platform uses advanced algorithms and clinical expertise to replicate a comprehensive psychiatric assessment. Users are guided through a series of adaptive questions, which help build a detailed understanding of their mental health. The result is a diagnostic report that is reviewed and signed off by a practicing psychiatrist, ensuring clinical accuracy.

Psyomics serves a diverse range of clients, including individuals seeking mental health support and healthcare providers looking to enhance their diagnostic capabilities. The company operates in the digital health market, which is rapidly growing due to increasing awareness and acceptance of mental health issues.

The business model of Psyomics is based on a combination of direct-to-consumer sales and partnerships with healthcare providers. They generate revenue through subscription fees for their digital platform, as well as through licensing agreements with medical institutions and clinics. By offering a scalable and efficient diagnostic tool, Psyomics helps healthcare providers maximize their clinical capacity while improving patient experience.

In summary, Psyomics leverages cutting-edge technology and scientific research to offer a unique solution for mental health diagnosis and treatment. Their approach not only enhances diagnostic accuracy but also personalizes recommendations, empowering users to take control of their mental health journey.

Source: Dealroom company data

Psyomics in the Milton ecosystem

Live from Dealroom

The Psyomics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • European Innovation Council
  • AXA PPP International

Series A7 investors entered at this stage

  • Cambridge Enterprise
  • Parkwalk Advisors
  • Martlet
  • Jonathan Milner
  • Newable Private Investing
  • Meltwind
  • Business Growth Fund

Series B and later1 investor entered at this stage

  • UK Research and Innovation
Team profiled 16 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇬🇧 United Kingdom100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Psyomics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Psyomics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.